This invention is directed to heterocyclyl-substituted anilino phospholipase C inhibitor compounds useful in treating or ameliorating an inflammatory disorders and/or restenosis of the general formula (I):
1
and enantiomers, diastereomers and pharmaceutically acceptable salts thereof. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions affected by phospholipase modulation.
本发明涉及一种杂环取代的
苯胺磷脂酶C
抑制剂化合物,其通式为(I),可用于治疗或缓解炎症性疾病和/或一般公式(1)的再狭窄,包括对映体、非对映体和药学上可接受的盐。本发明还涉及包括本发明化合物的制药组合物以及治疗受
磷脂酶调节影响的疾病的方法。